chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Let me start off by stating that patient has been a perfectly healthy little boy from brith. He started walking when he turned a year old. He hasn't NEVER had any issues walking.  Patient had received his vacations (MMR, HIB, DTAP) on monday July 11. On Tuesday we started to notice him dragging his right foot and limping severely. He has to have Motrin in his system around the clock for him to even barely put pressure on his right leg. Took him in on Wednesday, Doctor looked over him and said to bring him back on Friday, if it wasn't any better. I took him in Friday morning because it wasn't no better, actually get worse. They took X-rays of his hips to see what was going on. They didn't see anything. Doctor said to give it over the weekend and if he wasn't any better by Monday morning to give them a call and they would refer him to a Pediatric Orthopedic specialist. Well this morning Monday 7/18/16 I called his pediatrician about getting him scheduled with a specialist and told me it could take about a week or two to get him in and if I wanted answers to take him to the ER. We arrived at hospital this morning. The Doctor ordered a full set of X-rays from the right hip to the foot and also order blood work. Everything once again came back normal on the X-rays but the blood work showed elevated inflammation markers. They had a orthopedic specialist took a look at him and diagnosed him with Toxic Synovitis (also called "Transient Synovitis") Which is inflammatory arthritis in the hip. Now reading through all the explanations of this diagnosis's its states that many viral illnesses can trigger this response, including the common cold, stomach flu, chicken pox, MUMPS, RUBELLA and other contagious diseases. Just so happen that he had been WALKING perfect since he turned a year old and he goes in for his 15 month shots containing the MMR and the following day he can't barely walk or even put pressure on his right foot. This diagnosis's clearly states that it could be triggered by the MUMPS or RUBELLA which is what he was exactly injected with the day before!! I would like an explanation on what this isn't mentioned as a side effect! It has been 7 days since receiving the shots and he is doing worse and not wanting to put any pressure on his foot!! PLEASE HELP. Thanks.
dose administered > 12 hours post-puncture; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose administered > 12 hours post-puncture) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039D21A, 039A21A and 031A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (dose administered > 12 hours post-puncture). On 02-Dec-2021, EXPIRED PRODUCT ADMINISTERED (dose administered > 12 hours post-puncture) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The vial was initially stored in the refrigerator was on 15th September 2021 and the date vial was first punctured was  on 23rd November 2021 at approximately 15:20.  No concomitant medications was provided. No treatment information was provided.   This case was linked to MOD-2021-406023 (Patient Link).
6 x 6.5 cm erythematous, warm, slightly tender plaque on left upper arm.
Fever 103.2 and entire body sorr, extreme lower back pain and nausea
Engerix-B pediatric dose given to adult; Adult received Engerix B pediatric; This case was reported by a pharmacist via call center representative and described the occurrence of underdose in a 49-year-old male patient who received HBV (Engerix B pediatric) (batch number DA224, expiry date unknown) for prophylaxis.   On 15th February 2017, the patient received the 1st dose of Engerix B pediatric. On 15th February 2017, unknown after receiving Engerix B pediatric, the patient experienced underdose and adult use of a child product. On an unknown date, the outcome of the underdose and adult use of a child product were unknown.   Additional Information: GSK Receipt Date: 27-SEP-2022 Reporter's Comments:  The pharmacist reported that pediatric dose was given to an adult patient. The Vaccine Administration Facility is the same as Primary Reporter. Agent was unable to pull up the lot number provided by the pharmacist but the pharmacist believed that it could potentially be a pediatric Engerix-B so adverse event was reported. The reporter gave consent to follow up. Additional Supportive Information: pediatric dose was given to an adult patient, which led to underdose and adult use of child product
On the following 2 nights (2/6/07 and 2/7/07) he had episodes of gasping along with tonic-clonic movements of arms and legs, resolved when awoken by his mother, followed by crying. No cyanosis No fever on 2/5/07.
1 day after vaccination, she developed fever, episodic abdominal pain - no local pain. After 3 days fever dx infectious colitis.
Sudden band of back pain all across lower back, very painful. Pain transitioned after about 30 minutes to waves of pain concentrated over right kidney. Waves of pain came approximately every 20 seconds and continued for approximately 4 hours.
Blurry vision in left eye.  Takes a long time to focus after opening eye lid.  Started a week after vaccination.
Right lateral thigh ~ 12 cm x 13 cm erythema, increased warmth, mild edema. (+) Central ~ 2.5 cm x 2.5 cm circular vesicolor rash around injection site. Right inguinal fold with enlarged, rubbery lymphatic nodes x2 ~ 0.5 cm diameter each, N/T to palpation.
Information has been received from a consumer (also a practicing chiropractor) referring to multiple unspecified patients of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not reported. An unspecified physician reported to the consumer that, on unknown dates, the patients had unspecified symptoms after the vaccinations of ZOSTAVAX (lot #, expiration date, dose and route were unknown). The outcome of the event was unknown. The causality assessment was not reported. This is one of several reports received from the same reporter. Additional information has been requested.
Headache  swelling and pain at injection site about 3 to 4 hours  Chills and nausea  about 12 hours
The pt had a flu shot on 12/4/01. She called on 12/6/01 and complained of redness, swelling and tenderness in her left upper arm where the injection was given. The pt came in to the clinic and I assessed her arm. Her upper left arm had a 3" by 2" patch of redness which was swollen, warm and tender to the touch. Recommended ice to site and to see her MD if it doesn't get better or if it gets worse.
Sore arm that night, next am fever, bad headache, fatigue/lethargy and worse arm pain today, fever, headache gone but red swollen tender area and injection site and sore in axilla.
PATIENT EXPERIENCED NUMBNESS IN RING FINGER AND LITTLE FINGER ON THE LEFT ARM 48 HOURS AFTER RECEIVING VACCINE. IT WENT AWAY EVENTUALLY, BUT NOT COMPLETELY. HAS AFFECTED HIS TYPING.
Large red spot on arm, warm to touch bright red in morning, less red at night, but still visible.
LEFT UPPER ARM PAIN, SWELLING, AND WARM TO THE TOUCH MEASURING 5X5 CM. SYMPTOMS STARTED ON 2/19/09 AM. PT SEEN BY DR ON 2/20/2009 AND GIVEN RX FOR KEFLEX AND TYLENOL.
became agitated; delusional; patient got a temperature of 102 degrees Farenheight/fever did return the next morning.; This spontaneous case was reported by a patient family member or friend and describes the occurrence of AGITATION (became agitated), DELUSION (delusional) and PYREXIA (patient got a temperature of 102 degrees Farenheight/fever did return the next morning.) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 034F21A, 001A21A and 007M20A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Nov-2021, the patient experienced AGITATION (became agitated), DELUSION (delusional) and PYREXIA (patient got a temperature of 102 degrees Farenheight/fever did return the next morning.). At the time of the report, AGITATION (became agitated), DELUSION (delusional) and PYREXIA (patient got a temperature of 102 degrees Farenheight/fever did return the next morning.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Nov-2021, Body temperature: 102 102 degrees Fahrenheit.         No Concomitant medication were reported.  The patient thought that he had to go somewhere wearing a suit and started putting a suit on. The patient went to the hospital and was given anti inflammatories. The patient's fever was brought under control and he was sent home with advice from the emergency room physician that the fever might return the next morning. The fever did return the next morning.   Most recent FOLLOW-UP information incorporated above includes: On 18-Jul-2022: Follow up contains no new information.
The patient accidentally received a pneumovax23 vaccine that was intended for his wife; he received the vaccine in error instead of his intended shingles vaccine.  Once the error was realized, he still received his shingles vaccine in the other arm. He had completed his pneumonia vaccine series in the past.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021 at 4:24 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 29-Apr-2021 at 4:24 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 49.13.  Concomitant products were not provided.  On 29-Apr-2021, Excursion time was 10 AM, temperature was 33, total doses given for the day was 201, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 19-Apr-2021, vial was moved to clinic on 29-Apr-2021. 5 vials were sent to clinic. Vaccine BUD date was 19-May-2021.  On 29-Apr-2021, vials were stored in cooler 1, at following time and temperature respectively, 9 AM: 36, 10 AM: 33, 11 AM: 44, 12 AM: 45, 1PM: 45, 2 PM: 44, 3 PM: 45, 4 PM: 44.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a brand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
The arm the patient got the vaccine in, on the forearm was painful and had a not raised rash. Started small area, got better and then had a bigger rash on the other side of the same arm. Itchiness where the rash is but only local to the forearm
pt recv vax;noted red spots on lower legs;red blotches over body;had no fever; took pt to PMD who observed wheals & flakes over trunk & extremities;no resp problems;tx w/ dph;hives gradually disappeared per mom;
Fever; Chills; Extreme fatigue; Confusion; This is a spontaneous report received from a contactable consumer, the patient. An 84-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EZ6207) in the right arm via an unspecified route on 19Mar2021 at 03:30 PM as a single dose (at the age of 84-years-old) for COVID-19 immunisation. Medical history included congestive heart failure. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6200) in the right arm via an unspecified route on 23Feb2021 at 03:30 PM as a single dose (at the age of 84-years-old) for COVID-19 immunisation. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccine. The patient had received other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021 at 10:00 AM, the patient had fever, chills, extreme fatigue, confusion. The patient did not receive any treatment for this event and the events didn't resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever, chills, extreme fatigue, confusion was recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
The patient received dose from vial beyond 30-day use by date; The patient received dose from vial beyond 30-day use by date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient received dose from vial beyond 30-day use by date) and PRODUCT STORAGE ERROR (The patient received dose from vial beyond 30-day use by date) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient received dose from vial beyond 30-day use by date) and PRODUCT STORAGE ERROR (The patient received dose from vial beyond 30-day use by date). On 23-Jun-2021, EXPIRED PRODUCT ADMINISTERED (The patient received dose from vial beyond 30-day use by date) and PRODUCT STORAGE ERROR (The patient received dose from vial beyond 30-day use by date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   no concomitant medication were reported  no treatment medication were reported  Date of Refrigeration 07 May 2021.
Vaccination area became extremely hot, itchy, red, swollen, hardened and coverered an area 6" x 8". I applied ice compresses.
Covid infection after first dose of Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid infection after first dose of Moderna vaccine) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced COVID-19 (Covid infection after first dose of Moderna vaccine). On 16-Apr-2021, COVID-19 (Covid infection after first dose of Moderna vaccine) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Apr-2021, SARS-CoV-2 test: positive (Positive) positive. On 16-Apr-2021, SARS-CoV-2 test: negative (Negative) negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications information was reported. No treatment medications were provided.
patient had denied having any other corona virus vaccine while access to state immunization records was down and later discovered she already received a dose
Neck swelling at dinner, feeling of swelling over entire left side by the end of the evening.  Severe pain.  I'd been told reaction may be minor, lasting 24-48 hours, nothing like what ensued.  By that evening I was unable to move or lift my head.  My husband had to hold my head and accompany me in order for me to get out of bed and go to the bathroom.  Pain severe.  Notified primary care physician.  Nothing I could take that I wasn't already taking.  Slept for 5 days with this pain.  Today, 9 days later, I still have residual neck pain and am unable to drive because of limited neck movement.  My research indicates I never should have been given this vaccine, having had RA, and telling the nurse this.  I even asked her why I needed the vaccine if I've had shingles as well as chicken pox, and she said there's a debate about that.
Reactive arthritis affecting the hands (left more than right) and right knee and ankles.   Given toradol in ER.  Given prednisone taper on 1/21/21.  No outcome yet
Patient reports receiving an Influenza vaccine yesterday. Area where injection was placed is swollen to about the size of an egg and seems to be continuing to swell. Patient also reports area is warm to the touch and painful. She denies a fever but has been taking IBU to help with the discomfort. Recommended patient place cold packs to area--if no relief today patient will go to Urgent Care for eval.
symptomatic as of 07/30/2021 with cough and diarrhea - reports COPD, chronic anemia, ischemic cardiomyopathy, and hypertension - admitted to hospital on 07/24/2021, discharged 07/30/2021 - returned to nursing home and placed on COVID unit to isolate - fully vaccinated, Pfizer, 01/12/2021, 02/02/2021 - other positive residents and staff at facility - expired under hospice care on 08/05/2021
Received vaccine after rubella titer came back not immune.  Vaccine given on 8/23/19.  Developed rash and stiffness to joints on 9/6/19.  Report incident to our office 9/9/19.  Her rash and stiffness to joints have diminished from initial encounter but wanted to report incident to our employee health office .
I have a lingering cough that has been going on since I received the vaccine.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COUGH (I have a lingering cough that has been going on since I received the vaccine.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (I have a lingering cough that has been going on since I received the vaccine.). At the time of the report, COUGH (I have a lingering cough that has been going on since I received the vaccine.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported  No treatment medications were provided
Heavy chest tightening; Experiencing vomiting; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Heavy chest tightening) and VOMITING (Experiencing vomiting) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST DISCOMFORT (Heavy chest tightening) and VOMITING (Experiencing vomiting). At the time of the report, CHEST DISCOMFORT (Heavy chest tightening) and VOMITING (Experiencing vomiting) outcome was unknown.            The concomitant medications were not reported. The treatment information was not provided.
I am having pain in my arm after getting the flu shot. Can't lift my arm or move it sideways w/o terrible pain. It is very sensitive where the injection was given high up on my right arm.
This was a booster shot. I previously had two shots of the Moderna vaccine. On the night of 11/6/21 I began seeing floaters which began with sparks of copper colored light in the corner of my left eye, on 11/8/21 this changed to what resembled light black smoke, the next day it changed to look more like stray stands of black hair and occasionally tiny spots mostly seen in the corner of my left eye. Today I still have these floaters. They are less pronounced, but still there.
Information has been received from a nurse concerning a female in her 20's who was vaccinated with the third dose of GARDASIL (lot# not available) on an unspecified date. Concomitant therapy included influenza virus vaccine (unspecified) on the opposite arm. Subsequently the patient experienced pain at the injection site after receiving the vaccine. The patient did not have adverse experience with the 1st and 2nd dose. At the reporting time the patient had not recovered. Additional information has been requested.
pt recv vax 18MAY95 & 9APR96 pt devel chicken pox w/over 30 lesions;pt recovered & no other complications were noted;no further details were provided;
Chest pain for over 24 hrs. I went to the hospital because I thought I was having a heart attack, all test came back negative. I have no family history of heart conditions, and I'm relatively healthy and active.
Back pain day 0-3 and 6. Abdominal pain day 3-4 and 6. Vomiting and blood in stool day 6. Visited ER day 6 due to unsubsiding abdominal pain and listed symptoms. Toradol given by IV elevated pain symptoms.  Surgeon decided to release me but if symptoms reoccur, more tests will be done. Had never had any previous issues.
Shingles vaccine, Shingrix,  second. Glaxo Smithlline Fever 100F,  tiredness, upset stomach, tenderness at injection site